ATP is released in the micromolar concentration range in the tumor environment [24] and ATP increases proliferation of MCF-7 human breast cancer cells via Ca2+-dependent PI3K/Akt pathways downstream of P2Y2 and/or P2Y4 purinergic receptors [25]. Here, P2RY1 is linked to breast cancer.